Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi)

por Chang Muñoz, Meilen, Murphy, Jennifer A., Wolff, Johannes E., Jonas, Brian A.
Publicado 2020

Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options

por Brown, Robert E., Buryanek, Jamie, Katz, Amanda M., Paz, Keren, Wolff, Johannes E.
Publicado 2016

Out-of-Hospital Emergencies in Children Under Palliative Home Care

por Hauch, Holger, El Mohaui, Naual, Wolff, Johannes E. A., Vaillant, Vera, Brill, Sabine, Schneck, Emmanuel, Ströter, Natascha, Sibelius, Ulf, Kriwy, Peter, Berthold, Daniel
Publicado 2021

A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid...

por Borthakur, Gautam, Odenike, Olatoyosi, Aldoss, Ibrahim, Rizzieri, David A., Prebet, Thomas, Chen, Chris, Popovic, Relja, Modi, Dimple A., Joshi, Rujuta H., Wolff, Johannes E., Jonas, Brian A.
Publicado 2021

Final results of the Choroid Plexus Tumor study CPT-SIOP-2000

por Wolff, Johannes E., Van Gool, Stefaan W., Kutluk, Tezer, Diez, Blanca, Kebudi, Rejin, Timmermann, Beate, Garami, Miklos, Sterba, Jaroslav, Fuller, Gregory N., Bison, Brigitte, Kordes, Uwe R.
Publicado 2022

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment

por Ottensmeier, Holger, Schlegel, Paul G., Eyrich, Matthias, Wolff, Johannes E., Juhnke, Björn-Ole, von Hoff, Katja, Frahsek, Stefanie, Schmidt, Rene, Faldum, Andreas, Fleischhack, Gudrun, von Bueren, Andre, Friedrich, Carsten, Resch, Anika, Warmuth-Metz, Monika, Krauss, Jürgen, Kortmann, Rolf D., Bode, Udo, Kühl, Joachim, Rutkowski, Stefan
Publicado 2020

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma

por Bharathy, Narendra, Berlow, Noah E., Wang, Eric, Abraham, Jinu, Settelmeyer, Teagan P., Hooper, Jody E., Svalina, Matthew N., Bajwa, Zia, Goros, Martin W., Hernandez, Brian S., Wolff, Johannes E., Pal, Ranadip, Davies, Angela M., Ashok, Arya, Bushby, Darnell, Mancini, Maria, Noakes, Christopher, Goodwin, Neal C., Ordentlich, Peter, Keck, James, Hawkins, Douglas S., Rudzinski, Erin R., Mansoor, Atiya, Perkins, Theodore J., Vakoc, Christopher R., Michalek, Joel E., Keller, Charles
Publicado 2019

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

por Yuda, Junichiro, Will, Christine, Phillips, Darren C., Abraham, Linu, Alvey, Cory, Avigdor, Abraham, Buck, Wayne, Besenhofer, Lauren, Boghaert, Erwin, Cheng, Dong, Cojocari, Dan, Doyle, Kelly, Hansen, T. Matthew, Huang, Kevin, Johnson, Eric F., Judd, Andrew S., Judge, Russell A., Kalvass, John C., Kunzer, Aaron, Lam, Lloyd T., Li, Rachel, Martin, Ruth L., Mastracchio, Anthony, Mitten, Mike, Petrich, Adam, Wang, Jin, Ward, James E., Zhang, Haichao, Wang, Xilu, Wolff, Johannes E., Bell-McGuinn, Katherine M., Souers, Andrew J.
Publicado 2023